| | | | | | | | | | | | | | | | In millions | | March 31, 2026 | | December 31, 2025 | (1) Other non-interest yielding receivables | | | | | | Prepaid expenses and other receivables | | $ | 222.8 | | | $ | 200.0 | | | Less | | | | | | Other tax receivables | | 48.5 | | | 39.0 | | | Derivative financial instruments | | 23.5 | | | 22.3 | | | Promissory notes | | 4.5 | | | 4.4 | | | Total | | $ | 146.3 | | | $ | 134.3 | | | | | | | (2) Other current liabilities | | | | | | Other current liabilities | | $ | 862.4 | | | $ | 1,002.8 | | | Less | | | | | | Other tax liabilities | | 74.2 | | | 73.6 | | | Derivative financial instruments | | 45.1 | | | 68.2 | | | Contingent consideration related to acquisitions | | 20.0 | | | 20.0 | | | Total | | $ | 723.1 | | | $ | 841.0 | |
(3)The values of the derivatives as per the unaudited condensed consolidated interim statement of financial position have been recorded as they are disclosed in the Company’s unaudited condensed consolidated interim statement of financial position and fair value reserve, and therefore cannot be reconciled with their actual fair values. The following table presents the changes in Level 3 items during the period: | | | | | | | | | | | | | | | | | | | | | | | | | | | | In millions | | Unlisted equity securities | | Promissory notes | | Available for sale receivables | | Contingent consideration related to acquisitions | | Opening balance January 1, 2026 | | $ | 14.3 | | | $ | 4.4 | | | $ | 58.5 | | | $ | 20.0 | | | Additions | | — | | | — | | | 44.8 | | | — | | | | | | | | | | | | Interest income recognized in the consolidated statement of income | | — | | | 0.1 | | | — | | | — | | | Exchange rate losses | | (0.1) | | | — | | | — | | | — | | | Closing balance March 31, 2026 | | $ | 14.2 | | | $ | 4.5 | | | $ | 103.3 | | | $ | 20.0 | |
|